Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: A retrospective cohort study

BMJ Open

Volumn 7, Issue 1, 2017, Pages

  Berni, Ellen ^a   De Voogd, Hanka ^b   Halcox, Julian P ^c   Butler, Christopher C ^d   Bannister, Christian A ^e   Jenkins Jones, Sara ^a   Jones, Bethan ^a   Ouwens, Mario ^b   Currie, Craig J ^a,f  

^a Global Epidemiology   (United Kingdom)

^b Mylan   (Netherlands)

^c SWANSEA UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Digital Health Labs   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CLARITHROMYCIN; CYTOCHROME P450 3A4; DOXYCYCLINE; ERYTHROMYCIN; FLUINDOSTATIN; OXYTETRACYCLINE; PENICILLIN V; PRAVASTATIN; ROSUVASTATIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DATA BASE; DISEASE ASSOCIATION; FEMALE; HEART ARRHYTHMIA; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PRESCRIPTION; RETROSPECTIVE STUDY; UPPER RESPIRATORY TRACT INFECTION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY; RESPIRATORY TRACT INFECTION; RISK FACTOR; UNITED KINGDOM;

AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; UNITED KINGDOM;

EID: 85010369272     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-013398     Document Type: Article

References (19)

1. Clayton TC, Thompson M, Meade TW. Recent respiratory infection, risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 2008;29:96-103.
2. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction, stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-18.
3. Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia, subsequent risk of cardiovascular disease. JAMA 2015;313:264-74.
4. Antzelevitch C, Sun ZQ, Zhang ZQ, et al. Cellular, ionic mechanisms underlying erythromycin-induced long QT intervals, torsade de pointes. J Am Coll Cardiol 1996;28:1836-48.
5. Joint Formulary Committee. British National Formulary (online). http://www.medicinescomplete.com (accessed 20 Aug 2015).
6. Svanström H, Pasternak B, Hviid A. Use of clarithromycin, roxithromycin, risk of cardiac death: cohort study. BMJ 2014;349: g4930.
7. Currie CJ, Berni E, Jenkins-Jones S, et al. Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis. BMJ 2014;349:g5493.
8. Clinical Practice Research Datalink (CPRD). Clinical Practice Research Datalink. http://www.cprd.com/intro.asp (accessed 04/05/2016).
9. Gallagher AM, Puri S, van Staa TP. Linkage of the General Practice Research Database (GPRD) with other data sources. Pharmacoepidemiol Drug Saf 2011;20:S230.
10. Health & Social Care Information Centre. Hospital Episode Statistics. http://www.hscic.gov.uk/hes (accessed 04/05/2016).
11. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends 1997;87:36-40.
12. Herrett E, Gallagher AM, Bhaskaran K, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015;44:827-36.
13. Herrett E, Thomas SL, Schoonen WM, et al. Validation, validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4-14.
14. Wong AYS, Root A, Douglas IJ, et al. Cardiovascular outcomes associated with use of clarithromycin: population based study. BMJ 2016;352:h6926.
15. Li DQ, Kim R, McArthur E, et al. Risk of adverse events among older adults following co-prescription of clarithromycin, statins not metabolized by cytochrome P450 3A4. CMAJ 2015;187:174-80.
16. Ray WA, Murray KT, Hall K, et al. Azithromycin, the risk of cardiovascular death. N Engl J Med 2012;366:1881-90.
17. Volberg WA, Koci BJ, Su W, et al. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002;302:320-7.
18. Abo-Salem E, Fowler JC, Attari M, et al. Antibiotic-induced cardiac arrhythmias. Cardiovasc Ther 2014;32:19-25.
19. Shaffer D, Singer S, Korvick J, et al. Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food, Drug Administration Adverse Event Reporting System. Clin Infect Dis 2002;35:197-200.